Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years
Launched by EMORY UNIVERSITY · Jun 7, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a program called Screening, Brief Intervention, and Referral to Treatment (SBIRT) to see how well it helps adults who have risky alcohol or substance use habits while they are visiting a sexual and reproductive health clinic. The researchers want to find out if this program can improve not just the use of alcohol and substances, but also the overall health, quality of life, and wellbeing of the participants. They are also interested in whether the effectiveness of SBIRT varies based on factors like ethnicity, age, gender, and whether the care is given in-person or through telemedicine.
To participate in this trial, individuals must be over 18 years old, live in the U.S., have access to the internet, and show signs of risky alcohol or substance use. Participants will either receive the SBIRT program or standard care, which typically does not include consistent follow-up or referrals for further treatment. Throughout the study, participants will fill out surveys at the start, 30 days later, and again after three months to help researchers understand the impact of the program. This trial is important because it aims to improve the way we care for individuals facing challenges with substance use during critical times in their lives, like during pregnancy or reproductive health visits.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Over the age of 18 years
- • U.S. residing
- • Have internet access (own a computer or smart phone)
- • Screen positive to one or more risky alcohol and substance use behaviors as determined by our standardized abbreviated instruments
- Exclusion Criteria:
- • Not capable of communicating (reading, speaking, writing) in English or Spanish
About Emory University
Emory University, a leading research institution located in Atlanta, Georgia, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Emory harnesses the expertise of its renowned faculty and state-of-the-art facilities to conduct cutting-edge research across various fields, including oncology, neurology, and infectious diseases. The university's commitment to ethical research practices and patient safety ensures that all clinical trials are designed to generate valuable data that can lead to significant therapeutic advancements. By fostering partnerships with local hospitals and community organizations, Emory strives to translate research findings into real-world applications, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Marlborough, Massachusetts, United States
Springfield, Massachusetts, United States
Worcester, Massachusetts, United States
Patients applied
Trial Officials
Kelli S Hall, MD
Principal Investigator
Columbia University
Justine Welsh, MD
Principal Investigator
Emory University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported